We are pleased to introduce our new EQA scheme program 2025:
We have optimized our 2025 INSTAND EQA Scheme Program to meet the highest quality standards. Our new features at a glance:
- In Clinical Chemistry in the field of urine diagnostics, the parameters aminolaevulinic acid and porphobilinogen are no longer in group 178 but in the new group 180.
- In the field of Haematology, the EQA schemes
- 820 - CLL-MRD Immunophenotyping,
- 821 - Plasma Cell Neoplasia-MRD Immunophenotyping and
- 822 - CAR-T-Cells are new to the program.
- The Microbiology program in the field of bacterial genome detection was expanded with the EQA scheme 548 - Bacterial Genome Detection - Multiplex Tests - PCR/NAT for Gastrointestinal Pathogens.
- The Immunology range has been expanded with three new EQA schemes:
- 654 - Granulocyte Function (Oxidative Burst),
- 655 - Granulocyte Function (Phagocytosis Test),
- 656 - Lymphozyte Transformation Test (LTT).
- As of 2025, we will offer native whole blood samples for the measurand glucose in the EQA scheme 800 for Point-Of-Care Testing (POCT).
- The current EQA scheme is available in our RV-Online System and our Website.
Please note: As of 2025, INSTAND e.V. is legally obliged to send the EQA scheme 425 - Mycobacterial Diagnostics 05 - Susceptibility testing of tuberculosis bacteria according to UN 2814 specifications. Unfortunately, according to UN 2814, shipping leads to a considerable cost increase in the EQA scheme, almost 12-fold. This increase is exclusively due to the costs for the legally obligatory transport according to UN 2814. All attempts by INSTAND e.V. to obtain exemptions were unsuccessful.